Translational andrology and urology · 2026
Feasibility and early outcomes of single-port robotic-assisted radical cystectomy with intracorporeal ileal conduit: an initial Spanish case series.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Brime-Menéndez Ricardo, Paesano Nahuel, Guerrero-Ramos Félix, García-Rojo Esther, Justo-Quintas Juan, Hevia-Palacios Vital, Barrientos Facundo, Sáenz-Calzada David, Belkahia Ghali, Romero-Otero Javier
Аннотация
BACKGROUND: Single-port robotic-assisted radical cystectomy (SP-RARC) with intracorporeal urinary diversion (ICUD) represents a novel, minimally invasive approach for the surgical management of muscle-invasive bladder cancer (MIBC). While its feasibility has been demonstrated in high-volume centers, clinical experience remains scarce. We report the first Spanish experience with SP-RARC and ICUD, including perioperative outcomes and early postoperative results.
CASE DESCRIPTION: A prospective case series registry including the first four patients who underwent SP-RARC with ICUD between April and June 2025 was conducted. All procedures were performed by a single high-volume robotic multiport surgeon using the da Vinci SP® platform. Surgical steps postoperative management and early outcomes were standardized and recorded. All procedures were successfully completed using a single-port approach, without conversion to multiport or open surgery. No intraoperative complications occurred. The mean operative time was 249 minutes, with a mean estimated blood loss of 500 mL, a mean lymph node yield of 18.5, and a mean hospital stay of 6 days. Two patients (50%) experienced minor postoperative complications (Clavien-Dindo grade I-II); one required readmission for intravenous antibiotic therapy due to a febrile urinary tract infection. Final pathology revealed pT4aN0, pT1N0, pT3aN0 and pT4aN1. Surgical margins were negative in all cases.
CONCLUSIONS: SP-RARC with intracorporeal ileal conduit reconstruction was technically achievable in this initial case series when performed at an experienced robotic center. Given the limited cohort size and short follow-up, these findings should be interpreted as preliminary feasibility data requiring further validation in larger multicenter studies.
CASE DESCRIPTION: A prospective case series registry including the first four patients who underwent SP-RARC with ICUD between April and June 2025 was conducted. All procedures were performed by a single high-volume robotic multiport surgeon using the da Vinci SP® platform. Surgical steps postoperative management and early outcomes were standardized and recorded. All procedures were successfully completed using a single-port approach, without conversion to multiport or open surgery. No intraoperative complications occurred. The mean operative time was 249 minutes, with a mean estimated blood loss of 500 mL, a mean lymph node yield of 18.5, and a mean hospital stay of 6 days. Two patients (50%) experienced minor postoperative complications (Clavien-Dindo grade I-II); one required readmission for intravenous antibiotic therapy due to a febrile urinary tract infection. Final pathology revealed pT4aN0, pT1N0, pT3aN0 and pT4aN1. Surgical margins were negative in all cases.
CONCLUSIONS: SP-RARC with intracorporeal ileal conduit reconstruction was technically achievable in this initial case series when performed at an experienced robotic center. Given the limited cohort size and short follow-up, these findings should be interpreted as preliminary feasibility data requiring further validation in larger multicenter studies.